Provided by Tiger Trade Technology Pte. Ltd.

Spruce Biosciences, Inc.

63.04
-6.0700-8.78%
Post-market: 63.040.00000.00%17:00 EDT
Volume:38.14K
Turnover:2.45M
Market Cap:86.49M
PE:-1.24
High:70.25
Open:69.00
Low:61.39
Close:69.11
52wk High:240.00
52wk Low:4.28
Shares:1.37M
Float Shares:850.80K
Volume Ratio:0.80
T/O Rate:4.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-50.8300
EPS(LYR):-96.3944
ROE:-109.24%
ROA:-36.41%
PB:2.03
PE(LYR):-0.65

Loading ...

Spruce Biosciences Secures $50 Million Loan Facility from Avenue Capital

Reuters
·
Jan 08

Spruce Biosciences Inc - Initial Funding of $15 Mln Extends Cash Runway Into 2027

THOMSON REUTERS
·
Jan 08

Spruce Biosciences Secures up to $50 Million in Growth Capital From Avenue Capital

THOMSON REUTERS
·
Jan 08

BUZZ-Oppenheimer starts Spruce Biosciences with "outperform" rating on rare disease strength

Reuters
·
Dec 23, 2025

Spruce Biosciences Coverage Assumed by HC Wainwright & Co. at Buy

Dow Jones
·
Dec 22, 2025

Refile-Spruce Biosciences, Inc. : H.c. Wainwright Assumes Coverage With Buy Rating and Target Price $220 (Clarifies to Say Assumes Coverage)

THOMSON REUTERS
·
Dec 22, 2025

Spruce Biosciences, Inc. : H.c. Wainwright Initiates Coverage With Buy Rating and Target Price $220

THOMSON REUTERS
·
Dec 22, 2025

Spruce Biosciences Sets New Director Compensation Terms with Stock Options and Retainers

Reuters
·
Dec 15, 2025

Spruce Biosciences Appoints Keli Walbert to Board of Directors

Reuters
·
Dec 15, 2025

Spruce Biosciences Appoints Proven Pharmaceutical Commercial Leader Keli Walbert to Board of Directors

THOMSON REUTERS
·
Dec 15, 2025

Spruce Biosciences Reprices Stock Options to Boost Employee Retention

Reuters
·
Dec 13, 2025

Spruce Biosciences Shares Rise After Upgrade From Leerink

MT Newswires Live
·
Dec 04, 2025

Spruce Biosciences Raised to Outperform From Market Perform by Leerink Partners

Dow Jones
·
Dec 03, 2025

Leerink Upgrades Spruce Biosciences to Outperform From Market Perform, Price Target is $160

MT Newswires Live
·
Dec 03, 2025

Spruce Biosciences Shares Add 2.6% Premarket After Leerink Partners Upgrades Rating to 'Outperform' From 'Market Perform'

THOMSON REUTERS
·
Dec 03, 2025

Top News Today: Stocks Mixed as AI Selloff Slows

Dow Jones
·
Nov 15, 2025

Spruce Biosciences Is Maintained at Market Outperform by Citizens

Dow Jones
·
Nov 11, 2025

Spruce Biosciences price target raised to $259 from $254 at Citizens JMP

TIPRANKS
·
Nov 11, 2025

Spruce Biosciences Q3 net loss narrows

Reuters
·
Nov 11, 2025

Spruce Biosciences reports Q3 EPS (14.58) vs. ($15.75) last year

TIPRANKS
·
Nov 11, 2025